Found: 26
Select item for more details and to access through your institution.
Dolutegravir/Lamivudine Efficacy and Safety Outcomes in People With HIV-1 With or Without Historical Resistance Results at Screening: 48-Week Pooled Analysis.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae365
- By:
- Publication type:
- Article
Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection Administration.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 6, p. 1, doi. 10.1093/ofid/ofae282
- By:
- Publication type:
- Article
Evaluating Diversity in Randomized Clinical Trials of Dolutegravir-Based Antiretroviral Therapy Regimens: Pooled 48-Week Analyses by Race, Sex, and Regional Subgroups.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac304
- By:
- Publication type:
- Article
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies.
- Published in:
- AIDS Research & Therapy, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12981-024-00604-9
- By:
- Publication type:
- Article
An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1.
- Published in:
- AIDS Research & Therapy, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12981-023-00507-1
- By:
- Publication type:
- Article
Feeding the Future.
- Published in:
- 2023
- By:
- Publication type:
- Poem
Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A comment on Hawkin's model.
- Published in:
- Journal of Curriculum & Supervision, 1991, v. 6, n. 4, p. 370
- By:
- Publication type:
- Article
Conserving Eden: The (European) East India Companies and their environmental policies on St....
- Published in:
- Comparative Studies in Society & History, 1993, v. 35, n. 2, p. 318, doi. 10.1017/S0010417500018399
- By:
- Publication type:
- Article
The Great El Niño of 1789–93 and its Global Consequences.
- Published in:
- Medieval History Journal, 2007, v. 10, n. 1/2, p. 75, doi. 10.1177/097194580701000203
- By:
- Publication type:
- Article
Automated identification of brain new lesions in multiple sclerosis using subtraction images.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Automated identification of brain new lesions in multiple sclerosis using subtraction images.
- Published in:
- Journal of Magnetic Resonance Imaging, 2014, v. 39, n. 6, p. 1543, doi. 10.1002/jmri.24293
- By:
- Publication type:
- Article
Prehistoric maritime migration in the Pacific islands: an hypothesis of ENSO forcing.
- Published in:
- Holocene, 2006, v. 16, n. 1, p. 1, doi. 10.1191/0959683606hl901ft
- By:
- Publication type:
- Article
Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study.
- Published in:
- Journal of Neurology, 2017, v. 264, n. 2, p. 304, doi. 10.1007/s00415-016-8341-7
- By:
- Publication type:
- Article
Changes in Inflammatory Biomarkers and Baseline Variables After Switching to Dolutegravir/Lamivudine(DTG/3TC) in 2 Randomized Clinical Trials of Virologically Suppressed Adults: 48-Week Pooled Analysis.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 272
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Dolutegravir/ Lamivudine by Baseline Regimen in Virologically Suppressed Adults: 48-Week Pooled Analysis.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 271
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Dolutegravir/ Lamivudine (DTG/3TC) in Treatment-Experienced, Virologically Suppressed PLHIV Aged ≥50 Years: Pooled Results From the TANGO and SALSA Studies.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 273
- By:
- Publication type:
- Article
Efficacy and safety outcomes by BMI category over 48 weeks in phase 3/3B cabotegravir and rilpivirine long-acting trials.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S308
- By:
- Publication type:
- Article
Impact of treatment adherence on efficacy of DTG + 3TC and DTG + TDF/FTC: pooled week 144 analysis of the GEMINI-1 and GEMINI-2 clinical studies.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S302
- By:
- Publication type:
- Article
Diverging Perceptions of Personal Moral Values and the Values of One's Religious Group.
- Published in:
- Journal for the Scientific Study of Religion, 2020, v. 59, n. 1, p. 119, doi. 10.1111/jssr.12644
- By:
- Publication type:
- Article
Post‐Critical Belief Scale and Scripture as Predictors of Prejudice.
- Published in:
- Journal for the Scientific Study of Religion, 2019, v. 58, n. 2, p. 526, doi. 10.1111/jssr.12594
- By:
- Publication type:
- Article
Distrust persists after subverting atheist stereotypes.
- Published in:
- Group Processes & Intergroup Relations, 2020, v. 23, n. 7, p. 1103, doi. 10.1177/1368430219874103
- By:
- Publication type:
- Article
CHARLES DARWIN AND THE FALKLAND ISLANDS.
- Published in:
- Polar Record, 1985, v. 22, n. 139, p. 413, doi. 10.1017/s0032247400005659
- By:
- Publication type:
- Article
Climactic Fears.
- Published in:
- Harvard International Review, 2002, v. 23, n. 4, p. 50
- By:
- Publication type:
- Article
Basudhara Roy’s Stitching a Home.
- Published in:
- Writers Editors Critics, 2022, v. 12, n. 1, p. 107
- By:
- Publication type:
- Article
Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 1, p. e34, doi. 10.1093/infdis/jiad580
- By:
- Publication type:
- Article